Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study

被引:6
|
作者
Huang, Guang-Ming [1 ]
Qiu, Yue [1 ]
Liu, Tao-Tao [1 ]
Lu, Jie-Jiu [1 ]
机构
[1] Guangxi Med Univ, Dept Pharm, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 62卷 / 07期
基金
中国国家自然科学基金;
关键词
augmented renal clearance; critically ill infant; normal renal function; population pharmacokinetics; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; PEDIATRIC-PATIENTS; TROUGH CONCENTRATIONS; FEBRILE NEUTROPENIA; CYTOKINES; EXPOSURE; CHILDREN; OUTCOMES;
D O I
10.1002/jcph.2029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Augmented renal clearance presents as super-renal function with enhanced renal perfusion and glomerular hyperfiltration in many critically ill infants. This study was to compare vancomycin clearance (CL) between critically ill infants with augmented renal clearance and with normal renal function and to optimize the vancomycin dosage. Data were retrospectively obtained from infants treated in intensive care units. Population pharmacokinetics analysis was conducted using nonlinear mixed-effects model software. A total of 66 critically ill infants were included: 47 infants with augmented renal clearance and 19 infants with normal renal function. The median doses of vancomycin for infants with augmented renal clearance and with normal renal function were 48 and 47 mg/kg/day (P > .05), respectively. The median CL in infants with augmented renal clearance was increased 1.96-fold compared with infants who had normal renal function (0.98 versus 0.5 L/h, P < .001). Simulations indicated that the recommended dosage of 60, 70, 80, 90, and 100 mg/kg/day would be appropriate in critically ill infants with an estimated glomerular filtration rate (eGFR) of 130-149, 150-169, 170-189, 190-209, and >210 mL/min/1.73 m(2), respectively. Doses of 70 and 75 mg/kg/day were recommended for infants with augmented renal clearance and gestational ages of 27-32.9 and 33-39 weeks, respectively. Doses of 70, 75, 80, and 90 mg/kg/day were recommended for infants with augmented renal clearance and weights of 2.0-2.9, 3.0-3.9, 4.0-4.9, and 5.0-6.0 kg, respectively. In conclusion, the typical vancomycin dosage is insufficient for critically ill infants with augmented renal clearance. Premature infants and infants of low weight with augmented renal clearance need individualized dosing regimens to obtain an adequate area under the serum concentration time curve over 24 h/minimum inhibitory concentration ratio.
引用
收藏
页码:863 / 872
页数:10
相关论文
共 50 条
  • [21] A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
    João Pedro Baptista
    Andrew A Udy
    Eduardo Sousa
    Jorge Pimentel
    Lisa Wang
    Jason A Roberts
    Jeffrey Lipman
    Critical Care, 15
  • [22] Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations
    Udy, Andrew A.
    Baptista, Joao P.
    Lim, Noelle L.
    Joynt, Gavin M.
    Jarrett, Paul
    Wockner, Leesa
    Boots, Robert J.
    Lipman, Jeffrey
    CRITICAL CARE MEDICINE, 2014, 42 (03) : 520 - 527
  • [23] Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically III Children with Normal and Augmented Renal Clearance
    Beranger, Agathe
    Benaboud, Sihem
    Urien, Saik
    Moulin, Florence
    Bille, Emmanuelle
    Lesage, Fabrice
    Zheng, Yi
    Genuini, Mathieu
    Gana, Ines
    Renolleau, Sylvain
    Hirt, Deborah
    Treluyer, Jean-Marc
    Oualha, Mehdi
    CLINICAL PHARMACOKINETICS, 2019, 58 (02) : 223 - 233
  • [24] Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
    Du, Bin
    Zhou, Yue
    Tang, Bo-Hao
    Wu, Yue-E
    Yang, Xin-Mei
    Shi, Hai-Yan
    Yao, Bu-Fan
    Hao, Guo-Xiang
    You, Dian-Ping
    van den Anker, John
    Zheng, Yi
    Zhao, Wei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] PREDICTORS OF AUGMENTED RENAL CLEARANCE IN CRITICALLY ILL PATIENTS WITH CANCER
    Nazer, Lama
    Sheikha, Lama
    Anabtawi, Nadeen
    Le, Jennifer
    CRITICAL CARE MEDICINE, 2019, 47
  • [26] Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
    Bilbao-Meseguer, Idoia
    Rodriguez-Gascon, Alicia
    Barrasa, Helena
    Isla, Arantxazu
    Angeles Solinis, Maria
    CLINICAL PHARMACOKINETICS, 2018, 57 (09) : 1107 - 1121
  • [27] Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
    Idoia Bilbao-Meseguer
    Alicia Rodríguez-Gascón
    Helena Barrasa
    Arantxazu Isla
    María Ángeles Solinís
    Clinical Pharmacokinetics, 2018, 57 : 1107 - 1121
  • [28] Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
    Udy, Andrew A.
    Roberts, Jason A.
    Boots, Robert J.
    Paterson, David L.
    Lipman, Jeffrey
    CLINICAL PHARMACOKINETICS, 2010, 49 (01) : 1 - 16
  • [29] Augmented Renal Clearance in Critically Ill: Advantage or Threat Reply
    Udy, Andrew A.
    Baptista, Joao P.
    Lim, Noelle L.
    Joynt, Gavin M.
    Jarrett, Paul
    Boots, Robert J.
    Lipman, Jeffrey
    CRITICAL CARE MEDICINE, 2014, 42 (08) : E602 - E603
  • [30] Augmented renal clearance: a common condition in critically ill children
    Tatjana Van Der Heggen
    Evelyn Dhont
    Harlinde Peperstraete
    Joris R. Delanghe
    Johan Vande Walle
    Peter De Paepe
    Pieter A. De Cock
    Pediatric Nephrology, 2019, 34 : 1099 - 1106